Currently, out of the existing stock ratings of Christopher Pasquale - 8 which are a Hold (30.77%), 18 which are a Buy (69.23%)

Christopher Pasquale

Work Performance Price Targets & Ratings Chart

Analyst Christopher Pasquale works at GUGGENHEIM and is covering the Healthcare sector with 57 price targets and ratings displayed on 11 stocks.

Christopher Pasquale's average stock forecast success ratio is 63.03% with an average time for price targets to be met of 114 days.

Most recent stock forecast was given on PRCT, at 09-Mar-2022.

Wall Street Analyst Christopher Pasquale

Analyst best performing recommendations are on PRCT.
The best stock recommendation documented was for PRCT at 10/12/2021. The price target of $45 was fulfilled within 1 day with a profit of $1.86 (4.31%) receiving and performance score of 43.12.

Average potential price target upside

of $14.18 (29.3%) on ABT (ABBOTT LABORATORIES).
of $11.54 (12.35%) on DXCM (DEXCOM).
of $11.23 (12.85%) on PODD (INSULET).

DXCM DexCom ZBH Zimmer Biomet Holdings COO The Cooper Companies ABMD Abiomed ABT Abbott Laboratories CSII Cardiovascular Systems INSP Inspire Medical Systems MDT Medtronic plc PODD Insulet PRCT VRAY ViewRay

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Jayson Bedford (RAYMOND JAMES)